Estonia

Sales of analgesics return to their pre-pandemic performance in 2023. After the pandemic, seasonal colds and flus circulated more in the country as consumers socialised more without wearing masks, and sales of analgesics have returned to their usual…

Many OTC categories in Estonia, including cough and cold, experienced strong decline during COVID-19; however, sales are returning to their pre-pandemic performance in 2023 as viral illness are circulating more following the lifting of pandemic…

Whilst the category continues to record growth in 2023, the particularly high growth level seen in the previous year could not be maintained. 2022 was a strong year for the category as consumers returned to their pre-pandemic lifestyles following the…

Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy…

Post-pandemic habits are driving the growth of dietary supplements in 2023. During COVID-19, sales of dietary supplements increased in Estonia, with consumers seeking products to aid immunity and remain healthy, and sales continue to be supported by…